Skip to main content

Table 3 genotype/phenotype correlation in DADA2

From: Monogenic polyarteritis: the lesson of ADA2 deficiency

Mutation

Exon

N° of patients

Associated symptoms (% of patients)

M1T

2

1 in heterozygosis

Fever

Skin: Non-Langerhans cell histiocytosis

CNS/PNS: ischemic stroke

Visceral: involvement: hepatomegaly, splenomegaly. portal hypertension, hypertension (100 %)

K13del

2

2 in heterozygosis

Fever (50 %)

Skin: Livedo racemosa (50 %), skin nodules (50 %)

Immune/hematologic system: hypogammaglobulinemia (100 %), recurrent infections (50 %)

28-kb-deletion

2

1 in heterozygosis

Fever

Skin: Livedo reticularis, urticarial rash

CNS/PNS: ischemic and haemorrhagic strokes

Visceral involvement: hepatomegaly, splenomegaly. chronic gastritis

Immune/hematologic system: leukopenia, hypogammaglobulinemia (100 %)

G47R

2

27 in homozygosis

Fever (64 %)

Skin: Livedo reticularis (60 %), skin nodules (35 %), ulcerations at extremities/digital necrosis (32 %), Raynaud’s phenomenon (28 %), purpuric/vasculitic rash (18 %), erythema nodosum (18 %), panniculitis (3 %)

CNS/PNS: ischemic stroke (21 %), hemorrhagic stroke (7 %), intracranial haemorrhage (11 %), cranial nerve paralysis (14 %), polineuropathy (11 %), neurosensorial hearing loss (3 %).

Visceral involvement: abdominal pain (21 %), intestinal vasculitis (14 %), hepatomegaly (3 %), splenomegaly (7 %), hypertransaminasemia (3 %), hypertension (25 %).

Immune/hematologic system: Leucopoenia (3 %), anaemia (3 %), lymphadenopathy (3 %).

1 in heterozygosis

G47A

2

2 in heterozygosis

Fever (100 %)

Skin: Livedo reticularis (100 %), urticarial rash (100 %)

CNS/PNS: ischemic and haemorrhagic strokes (100 %)

Visceral involvement: hepatomegaly (100 %), splenomegaly (100 %), portal hypertension (100 %)

Immune/hematologic system: Pancytopenia (100 %), hypogammaglobulinemia (100 %).

G47V

2

1 in heterozygosis

Fever

Skin: Livedo reticularis

Visceral involvement: hypertension, abdominal and renal aneurysm (100 %).

I93T

2

1 in heterozygosis

Fever

Skin: Non-Langerhans cell histiocytosis

CNS/PNS: ischemic stroke

Visceral: involvement: hepatomegaly, splenomegaly. portal hypertension, hypertension (100 %)

A109D

3

1 in heterozygosis

Fever

Skin: Livedo reticularis

CNS/PNS: ischemic stroke

Visceral involvement: splenomegaly (100 %).

H112Q

3

1 in heterozygosis

Fever

Skin: Livedo reticularis, urticarial rash

CNS/PNS: ischemic and haemorrhagic strokes

Visceral involvement: hepatomegaly, splenomegaly, portal hypertension

Immune/hematologic system: Pancytopenia, hypogammaglobulinemia (100 %).

T119A

3

4 in heterozygosis

Fever (100 %)

Skin: Livedo reticularis, ulceration of extremities (100 %)

CNS/PNS: ischemic and haemorrhagic strokes (100 %)

G142S

3

4 in heterozygosis

Fever (100 %)

Skin: Livedo reticularis, ulceration of extremities (100 %)

CNS/PNS: ischemic and haemorrhagic strokes (100 %)

R169Q

3

15 in homozygosis

Fever (37 %)

Skin: Livedo reticularis (58 %), skin nodules (4 %), ulcerations at extremities/digital necrosis (8 %), Raynaud’s phenomenon (8 %), purpuric/vasculitic rash (13 %), erythema nodosum (13 %), eczema (20 %)

CNS/PNS: ischemic stroke (54 %), hemorrhagic stroke (13 %), intracranial haemorrhage (13 %), cranial nerve paralysis (37 %), polineuropathy (8 %), neurosensorial hearing loss (8 %).

Visceral involvement: abdominal pain (17 %), bowel ulcerations (8 %), chronic gastritis (4 %), bowel stenosis (4 %), colitis (4 %), hepatomegaly (45 %), splenomegaly (58 %), acute liver failure (4 %), hypertension (8 %).

Immune/hematologic system: hypogammaglobulinemia (62 %), pancytopenia (8 %), leucopoenia (20 %), lymphopenia (13 %), granulocytopenia (4 %), anaemia (25 %), thrombocytopenia (4 %),

lymphadenopathy (25 %), recurrent infections (29 %).

9 in heterozygosis

P193L

4

1 in heterozygosis

Fever

Skin: Livedo reticularis, ulcerations at extremities

CNS/PNS: ischemic stroke, TIA, intracranial haemorrhage, polineuropathy

Visceral involvement: bowel stenosis, oral aphtae

Immune/hematologic system: hypogammaglobulinemia (100 %).

M243R

4

2 in heterozygosis

Fever (50 %)

Skin: erythema nodosum (50 %)

CNS/PNS: intracranial haemorrhage (50 %)

Visceral involvement: splenomegaly (100 %)

Immune/hematologic system: hypogammaglobulinemia (100 %), recurrent infections (100 %).

P251L

4

4 in heterozygosis

Fever (25 %)

Skin: Livedo reticularis (75 %), vasculitic rash (50 %)

CNS/PNS: ischemic stroke (75 %), cranial nerve paralysis (100 %), neurosensorial hearing loss (25 %).

Visceral involvement: hypertension (25 %), epididymitis (25 %)

W264S

5

1 in heterozygosis

Fever

Skin: Livedo reticularis

Visceral involvement: hypertension, abdominal and renal aneurysm (100 %).

R306*

6

1 in heterozygosis

Fever

Skin: rash

CNS/PNS: ischemic stroke, hemorrhagic stroke, intracranial haemorrhage (100 %)

N328K

7

2 in heterozygosis

Fever (50 %)

Skin: Livedo racemosa (50 %), skin nodules (50 %)

Immune/hematologic system: hypogammaglobulinemia (100 %), recurrent infections (50 %)

Y453C

9

3 in heterozygosis

Fever (100 %)

Skin: Livedo reticularis (100 %), urticarial rash (33 %)

CNS/PNS: ischemic stroke (100 %), haemorrhagic strokes (33 %)

Visceral involvement: hepatomegaly (66 %), splenomegaly (100 %), portal hypertension (33 %)

Immune/hematologic system: Pancytopenia (66 %), hypogammaglobulinemia (66 %).